Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
7.96
Oct 23 • 3:59 PM ET Dollar change+0.34 Percentage change(4.46%)
Aftermarket Close
7.93
Aftermarket • 7:30 PM ET Dollar change-0.03 Percentage change(-0.38%)
Category
Equity - Leveraged / Inverse
Sponsor
Direxion Shares
Fund Family
Index
S&P Biotechnology Select Industry Index
Index Weighting
Active/Passive
Expense
1.07%
Inverse/Leveraged
IPO
May 28, 2015
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
1.91%
SMA50
10.10%
SMA200
-36.78%
Return% 1Y
-74.36%
Return% 3Y
-66.60%
Return% 5Y
-46.73%
Return% 10Y
Return% SI
Flows% 1M
-51.38%
Flows% 3M
-12.31%
Flows% YTD
163.50%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
11
AUM
77.09M
NAV/sh
52W High
33.40 -76.17%
52W Low
5.81 37.01%
Volatility
8.69% 8.54%
ATR (14)
0.67
RSI (14)
52.33
Beta
-2.51
Rel Volume
0.86
Avg Volume
19.50M
Volume
16,675,178
Perf Week
-11.16%
Perf Month
9.79%
Perf Quarter
-9.03%
Perf Half Y
-43.86%
Perf YTD
-62.20%
Perf Year
-75.49%
Perf 3Y
-97.17%
Perf 5Y
-96.36%
Perf 10Y
-99.98%
Prev Close
7.62
Price
7.96
Change %
4.46%
Direxion Daily S&P Biotech Bear 3X Shares seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in swap agreements, futures contracts, short positions or other financial instruments that provide inverse (opposite) or short daily exposure to the index or to ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.